HR740

The Veterans' ACCESS Act of 2025, HR740, directly expands the Veterans Community Care Program (VCCP) by codifying eligibility standards for non-VA care, requiring prompt notification to veterans regarding eligibility, and extending claim submission deadlines for healthcare providers. This legislation mandates increased utilization of private sector healthcare services for veterans, moving beyond the VA's internal capacity. The bill's unanimous reporting out of committee by voice vote signals strong bipartisan support and high probability of passage. Funding for these expanded services flows from the Department of Veterans Affairs to private healthcare entities and managed care organizations. Companies that currently contract with the VA for community care services, or are positioned to do so, stand to gain. Managed care organizations like Centene Corporation ($CNC), UnitedHealth Group ($UNH), Humana ($HUM), and Molina Healthcare ($MOH) are primary beneficiaries due to their existing networks and experience in administering large-scale government healthcare programs. Additionally, pharmaceutical companies and medical device manufacturers, such as Procter & Gamble ($PG) and Johnson & Johnson ($JNJ), will see increased demand for their products as more veterans access care. Retail pharmacy chains like CVS Health ($CVS) and Walgreens Boots Alliance will also benefit from increased prescription volume. Historically, expansions of veteran healthcare benefits have led to increased revenue for private healthcare providers. For example, the VA MISSION Act of 2018, which consolidated and expanded community care programs, led to a significant increase in VA spending on private care. Following its passage, companies with substantial government contracts in healthcare saw sustained growth in their public sector divisions. While specific market reactions are difficult to isolate due to broader market dynamics, the trend has consistently been positive for private healthcare providers. The current bill builds on the framework established by the MISSION Act, further solidifying the role of private care. Specific winners include Centene Corporation ($CNC), UnitedHealth Group ($UNH), Humana ($HUM), and Molina Healthcare ($MOH) due to their extensive managed care networks and government contracting experience. Pharmaceutical and medical supply companies like Procter & Gamble ($PG) and Johnson & Johnson ($JNJ) will see increased demand for their products. CVS Health ($CVS) and Walgreens Boots Alliance will benefit from higher prescription volumes. There are no clear losers, as the bill expands access rather than restricting it. This bill has been ordered to be reported (amended) by voice vote, indicating it has cleared a significant hurdle in the legislative process. The next steps involve a floor vote in the House, followed by consideration in the Senate. Given the bipartisan support and the nature of veteran benefits legislation, passage is highly probable within the current legislative session.